ReachMD

Janet B. McGill, MD, is currently Associate Professor of Medicine at Washington University School of Medicine and Attending Consultant at Barnes-Jewish Hospital in St. Louis, Missouri. She has been active in clinical research for over 20 years, beginning with the Diabetes Control and Complications Trial and the Captopril in Diabetic Nephropathy study. Dr. McGill has continued to work on multicenter trials in diabetes treatments, prevention, and complications such as retinopathy, nephropathy, and neuropathy. She has served on steering committees for the RENAAL and GEMINI studies, and more recently, the TREAT, SUN-MICRO, and overt studies in diabetic nephropathy and FOCAL study in diabetic retinopathy. Dr. McGill's research interests include treatment of diabetes and its complications, novel approaches to the metabolic syndrome, and fuel metabolism of the heart.

Dr. McGill is a member of the American Diabetes Association (ADA) and serves on the ADA Eastern Missouri Advisory Board. She is also a member of the National Kidney Foundation and has been a member of the steering committee for the Kidney Early Evaluation Program. She serves on the Medical Staff Council of Barnes-Jewish Hospital and on several committees.

Additionally, Dr. McGill is a member of the editorial boards for several journals, and has published numerous peer-reviewed articles and chapters including a review of incretin biology in type 2 diabetes.